Organisation paid for research Program year 2025 Source: CMS Open Payments

Texas Health Physicians Group

Neither a doctor nor a teaching hospital

Research payments

$1,088,831

681 payments

Through program year 2025, Texas Health Physicians Group is reported as receiving $1,088,831 in research payments, across 681 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $98,842 10
2024 Research $166,587 21
2023 Research $146,286 35
2022 Research $116,862 144
2021 Research $259,108 279
2020 Research $87,654 116
2019 Research $213,491 76

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $484,926 602 payments
  2. Zimmer Biomet Holdings, Inc. $229,430 24 payments
  3. Novartis Pharmaceuticals Corporation $172,873 9 payments
  4. Exact Sciences Corporation $88,525 19 payments
  5. Kyocera Medical Technologies, Inc. $49,525 5 payments
  6. Amgen Inc. $31,617 15 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $27,435 5 payments
  8. Eisai Inc. $4,500 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. Ex9536-4388 $342,359 563 payments
  2. MDR - Taperloc Complete/Stems $138,450 2 payments
  3. Nn9536-4375 $112,699 30 payments
  4. Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $102,084 6 payments
  5. MDR - Taperloc Complete/Stems $76,880 17 payments
  6. A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) $70,790 3 payments
  7. A Prospective, Post-market, Mutli-center Study of the Initia Hip System and BIOCERAM AZUL HEADREview the $49,525 5 payments
  8. A Real World Study of Patients Under the Age of 50 Screened for Colorectal Cancer (CRC) Using Cologuard in the U.S. "Tidal $38,929 2 payments
  9. Nn2211-4232 $29,868 9 payments
  10. COPD pragmatic randomised clinical trial $27,435 5 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $38,975 3 payments
  2. Overhead $10,550 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record